speb/financial-data huggingface dataset:
Financial ratios for GRBK — quarterly report dated 2025-06-30
Total revenue: 549147000
Gross profit: 167514000
Operating income: 107742000
Net income: 89331000
Capital expenditures: 687000
Operating cash flow: 74713000
Depreciation & amortization: 1082000
Net tangible assets: 1724454000
Owner earnings: 89726000
Return on net tangible assets (%): 5.203154157779796
Capex to operating income (%): 0.6376343487219468
Buffett classification: The Great
Stock price: 62.88
P/E ratio: 15.65850204183405
Shares outstanding: 43144552
Book value: 1794902000
P/B ratio: 1.5114638179466067
Market cap (USD): 2712929429.76
Debt to equity: 0.16673333697327208
Current ratio: 13.296422341762115
Quick ratio: 1.2392932508752028
Effective tax rate (%): 20.444749216300938
COGS to revenue (%): 69.49559953892127
R&D to revenue (%): 0.0433399435852331
SG&A to revenue (%): 10.84117731682045
Free cash flow (dilution-adjusted): 72636000
Buyback yield (%): 1.6151175743585884
Retained earnings: 1433328000
Inventory turnover: 0.19304510926389706
Receivables turnover: 13.075862561611544
Capitalized R&D asset: 336490
ROCI (R&D-adjusted, %): 5.012524945137016
Rosenberg metric: 67.48299319727892
FCF margin (%): 13.227059421247864
Revenue growth (%): 12.2265593067931
Rule of 40 score: 25.453618728040965
Financial ratios for GRBK — quarterly report dated 2025-09-30
Total revenue: 499091000
Gross profit: 155462000
Operating income: 97322000
Net income: 83409000
Capital expenditures: 1824000
Operating cash flow: -10193000
Depreciation & amortization: 1472000
Net tangible assets: 1803264000
Owner earnings: 83057000
Return on net tangible assets (%): 4.605925699176605
Capex to operating income (%): 1.8741908304391608
Buffett classification: The Great
Stock price: 73.86
P/E ratio: 12.415625857518554
Shares outstanding: 43144552
Book value: 1878936000
P/B ratio: 1.6959899702384753
Market cap (USD): 3186656610.72
Debt to equity: 0.1854597495603895
Current ratio: 8.99974115783577
Quick ratio: 0.8864107863779482
Effective tax rate (%): 21.78084118722746
COGS to revenue (%): 68.85097106539689
R&D to revenue (%): 0.08435335439829611
SG&A to revenue (%): 11.564824851580173
Free cash flow (dilution-adjusted): -13361000
Buyback yield (%): 0
Retained earnings: 1510462000
Inventory turnover: 0.16362545503893872
Receivables turnover: 12.395772793880237
Capitalized R&D asset: 628970
ROCI (R&D-adjusted, %): 4.384496774575384
Rosenberg metric: -50.63865546218487
FCF margin (%): -2.677066907638086
Revenue growth (%): -9.115227798749698
Rule of 40 score: -11.792294706387784
Financial ratios for GRBK — annual report dated 2025-12-31
Total revenue: 2039994000
Gross profit: 640806000
Operating income: 409443000
Net income: 343511000
Capital expenditures: 4798000
Operating cash flow: 213244000
Depreciation & amortization: 5111000
Net tangible assets: 1858085000
Owner earnings: 343824000
Return on net tangible assets (%): 18.50421267057212
Capex to operating income (%): 1.1718358843599719
Buffett classification: The Great
Stock price: 62.66
P/E ratio: 7.870017636465789
Shares outstanding: 43144552
Book value: 1932985000
P/B ratio: 1.3985817936093659
Market cap (USD): 2703437628.3199997
Debt to equity: 0.17015807158358703
Current ratio: 7.964724447196533
Quick ratio: 0.9761600383516769
Effective tax rate (%): 21.60469033132654
COGS to revenue (%): 68.58784878779055
SG&A to revenue (%): 11.341356886343783
Free cash flow (dilution-adjusted): 196123000
Buyback yield (%): 3.098647408117097
Retained earnings: 1567111000
Inventory turnover: 0.6665304250025367
Receivables turnover: 51.02281026461908
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.32460686120456
FCF margin (%): 9.613900825198506
Revenue growth (%): -1.0420208831055433
Rule of 40 score: 8.571879942092963
Financial ratios for GRBK — quarterly report dated 2025-12-31
Total revenue: 552612000
Gross profit: 162045000
Operating income: 103489000
Net income: 86846000
Capital expenditures: 1574000
Operating cash flow: 79977000
Depreciation & amortization: 1152000
Net tangible assets: 1858085000
Owner earnings: 86424000
Return on net tangible assets (%): 4.651240389971395
Capex to operating income (%): 1.5209345920822503
Buffett classification: The Great
Stock price: 62.66
P/E ratio: 7.870017636465789
Shares outstanding: 43144552
Book value: 1932985000
P/B ratio: 1.3985817936093659
Market cap (USD): 2703437628.3199997
Debt to equity: 0.17015807158358703
Current ratio: 7.964724447196533
Quick ratio: 0.9761600383516769
Effective tax rate (%): 23.217837976429397
COGS to revenue (%): 70.67653254000999
SG&A to revenue (%): 10.742075814495523
Free cash flow (dilution-adjusted): 76947000
Buyback yield (%): 0.8520263148927923
Retained earnings: 1567111000
Inventory turnover: 0.18605418893098408
Receivables turnover: 13.821519683857735
Capitalized R&D asset: 360610
ROCI (R&D-adjusted, %): 4.621069531513793
Rosenberg metric: 15.636579572446555
FCF margin (%): 13.924236172938699
Revenue growth (%): 10.723695678743956
Rule of 40 score: 24.647931851682657
Financial ratios for IBEX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.52
Shares outstanding: 13389116
Market cap (USD): 261355544.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBEX — annual report dated 2022-06-30
Total revenue: 492851000
Gross profit: 118878000
Operating income: 20625000
Net income: 21456000
Capital expenditures: 25919000
Operating cash flow: 40006000
Depreciation & amortization: 18100000
Net tangible assets: 101627000
Owner earnings: 13637000
Return on net tangible assets (%): 13.418678107195921
Capex to operating income (%): 125.66787878787879
Buffett classification: The Gruesome
Stock price: 16.87
P/E ratio: 10.527329740865026
Shares outstanding: 13389116
Book value: 113459000
P/B ratio: 1.9908018484210157
Market cap (USD): 225874386.92000002
Debt to equity: 0.9302214897011255
Current ratio: 1.4559187514063043
Quick ratio: 1.4559187514063043
Effective tax rate (%): -10.717787295526085
Interest coverage ratio: 16.00077579519007
COGS to revenue (%): 75.87952545495494
SG&A to revenue (%): 83.97203211518288
Free cash flow (dilution-adjusted): 12236000
Buyback yield (%): 1.5079177619223971
Retained earnings: -76360000
Receivables turnover: 6.0235269674044565
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.501206684113521
FCF margin (%): 2.482697610433985
Rule of 40 score: 2.482697610433985
Financial ratios for IBEX — annual report dated 2023-06-30
Total revenue: 523118000
Gross profit: 148126000
Operating income: 40478000
Net income: 31582000
Capital expenditures: 18952000
Operating cash flow: 41859000
Depreciation & amortization: 18985000
Net tangible assets: 138132000
Owner earnings: 31615000
Return on net tangible assets (%): 22.887527871890654
Capex to operating income (%): 46.8204950837492
Buffett classification: The Good
Stock price: 21.23
P/E ratio: 9.000409495282122
Shares outstanding: 13389116
Book value: 149964000
P/B ratio: 1.8954611285375156
Market cap (USD): 284250932.68
Debt to equity: 0.5261462751060254
Current ratio: 2.1649581632792345
Quick ratio: 2.1649581632792345
Effective tax rate (%): 21.683281257749343
Interest coverage ratio: 51.10858585858586
COGS to revenue (%): 71.6840177550763
SG&A to revenue (%): 16.94894842081519
Free cash flow (dilution-adjusted): 18301000
Buyback yield (%): 0.0970973067345082
Retained earnings: -44778000
Receivables turnover: 5.663166327458537
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.39382358688194
FCF margin (%): 3.4984458573400268
Revenue growth (%): 6.141206977362327
Rule of 40 score: 9.639652834702353
Financial ratios for IBEX — annual report dated 2024-06-30
Total revenue: 508569000
Gross profit: 152033000
Operating income: 39429000
Net income: 33655000
Capital expenditures: 8855000
Operating cash flow: 35900000
Depreciation & amortization: 19461000
Net tangible assets: 153967000
Owner earnings: 44261000
Return on net tangible assets (%): 28.74706917716134
Capex to operating income (%): 22.45808922366786
Buffett classification: The Great
Stock price: 16.18
P/E ratio: 6.436960240083198
Shares outstanding: 13389116
Book value: 165799000
P/B ratio: 1.3066176326757097
Market cap (USD): 216635896.88
Debt to equity: 0.40421836078625323
Current ratio: 2.534762521832216
Quick ratio: 2.534762521832216
Effective tax rate (%): 17.886595422827305
Interest coverage ratio: 76.71011673151752
COGS to revenue (%): 70.10572803297094
SG&A to revenue (%): 18.31472228940419
Free cash flow (dilution-adjusted): 23280000
Buyback yield (%): 9.950336167943766
Retained earnings: -11123000
Receivables turnover: 4.724809082294357
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.688463401941608
FCF margin (%): 4.577549948974475
Revenue growth (%): -2.7812080639549777
Rule of 40 score: 1.7963418850194977
Financial ratios for IBEX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 21.49
Shares outstanding: 13389116
Market cap (USD): 287732102.84
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBEX — quarterly report dated 2025-03-31
Total revenue: 140736000
Gross profit: 44719000
Operating income: 13329000
Net income: 10502000
Capital expenditures: 5267000
Operating cash flow: 8828000
Depreciation & amortization: 4329000
Net tangible assets: 112349000
Owner earnings: 9564000
Return on net tangible assets (%): 8.512759348102787
Capex to operating income (%): 39.51534248630805
Buffett classification: The Good
Stock price: 24.35
P/E ratio: 7.761021105503714
Shares outstanding: 13389116
Book value: 124181000
P/B ratio: 2.6254014269493724
Market cap (USD): 326024974.6
Debt to equity: 0.7389697296687899
Current ratio: 1.670194360184249
Quick ratio: 1.670194360184249
Effective tax rate (%): 19.201975765995215
Interest coverage ratio: 32.992574257425744
COGS to revenue (%): 68.22490336516599
SG&A to revenue (%): 19.228200318326515
Free cash flow (dilution-adjusted): 1960000
Buyback yield (%): 7.6840739059135865
Retained earnings: 16145000
Receivables turnover: 1.1253388346486914
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.176894373818793
FCF margin (%): 1.3926784902228286
Rule of 40 score: 1.3926784902228286
Financial ratios for IBEX — quarterly report dated 2025-06-30
Total revenue: 147138000
Gross profit: 46266000
Operating income: 12262000
Net income: 9596000
Capital expenditures: 5159000
Operating cash flow: 27937000
Depreciation & amortization: 4248000
Net tangible assets: 122477000
Owner earnings: 8685000
Return on net tangible assets (%): 7.091127313699714
Capex to operating income (%): 42.07307127711629
Buffett classification: The Good
Stock price: 29.1
P/E ratio: 10.150668914130888
Shares outstanding: 13389116
Book value: 134309000
P/B ratio: 2.9009468881459917
Market cap (USD): 389623275.6
Debt to equity: 0.5193620680669203
Current ratio: 1.821580915925495
Quick ratio: 1.821580915925495
Effective tax rate (%): 18.97323313349658
Interest coverage ratio: 27.370535714285715
COGS to revenue (%): 68.55604942299067
SG&A to revenue (%): 20.223191833516836
Free cash flow (dilution-adjusted): 20852000
Buyback yield (%): 0.4088564774645101
Retained earnings: 25741000
Receivables turnover: 1.2395996562705354
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.344360855572917
FCF margin (%): 14.171729940599981
Revenue growth (%): 4.548942701227831
Rule of 40 score: 18.72067264182781
Financial ratios for IBEX — annual report dated 2025-06-30
Total revenue: 558273000
Gross profit: 172581000
Operating income: 46611000
Net income: 36864000
Capital expenditures: 18375000
Operating cash flow: 45668000
Depreciation & amortization: 17232000
Net tangible assets: 122477000
Owner earnings: 35721000
Return on net tangible assets (%): 29.165475966916237
Capex to operating income (%): 39.42202484392096
Buffett classification: The Good
Stock price: 29.1
P/E ratio: 10.569207779947916
Shares outstanding: 13389116
Book value: 134309000
P/B ratio: 2.9009468881459917
Market cap (USD): 389623275.6
Debt to equity: 0.5193620680669203
Current ratio: 1.821580915925495
Quick ratio: 1.821580915925495
Effective tax rate (%): 19.742227640860403
Interest coverage ratio: 28.525703794369644
COGS to revenue (%): 69.08662965968263
SG&A to revenue (%): 19.477567426689095
Free cash flow (dilution-adjusted): 21861000
Buyback yield (%): 20.02293109410941
Retained earnings: 25741000
Receivables turnover: 4.703305868675125
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.116539213758706
FCF margin (%): 3.915826128077123
Revenue growth (%): 9.77330509724344
Rule of 40 score: 13.689131225320564
Financial ratios for IBEX — quarterly report dated 2025-09-30
Total revenue: 151179000
Gross profit: 44602000
Operating income: 13699000
Net income: 12042000
Capital expenditures: 7639000
Operating cash flow: 15670000
Depreciation & amortization: 4378000
Net tangible assets: 131793000
Owner earnings: 8781000
Return on net tangible assets (%): 6.662721085338371
Capex to operating income (%): 55.76319439375137
Buffett classification: The Good
Stock price: 40.52
P/E ratio: 16.880117620410704
Shares outstanding: 13389116
Book value: 143625000
P/B ratio: 3.7773854156309836
Market cap (USD): 542526980.32
Debt to equity: 0.4632967798085292
Current ratio: 1.8182597309844066
Quick ratio: 1.8182597309844066
Effective tax rate (%): 10.879218472468917
Interest coverage ratio: 63.12903225806452
COGS to revenue (%): 70.49722514370383
SG&A to revenue (%): 17.545426282750913
Free cash flow (dilution-adjusted): 5481000
Buyback yield (%): 0.510020717931472
Retained earnings: 37783000
Receivables turnover: 1.2862247632660353
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.854743879067486
FCF margin (%): 3.6255035421586332
Revenue growth (%): 2.7464013375198792
Rule of 40 score: 6.371904879678512
Financial ratios for IBEX — quarterly report dated 2025-12-31
Total revenue: 164221000
Gross profit: 47592000
Operating income: 15287000
Net income: 12217000
Capital expenditures: 11732000
Operating cash flow: 6644000
Depreciation & amortization: 4750000
Net tangible assets: 142683000
Owner earnings: 5235000
Return on net tangible assets (%): 3.6689724774500116
Capex to operating income (%): 76.74494668672729
Buffett classification: The Gruesome
Stock price: 38.18
P/E ratio: 11.524594739950853
Shares outstanding: 13389116
Book value: 154515000
P/B ratio: 3.308393676212665
Market cap (USD): 511196448.88
Debt to equity: 0.41640617415784875
Current ratio: 1.8325414715912376
Quick ratio: 1.8325414715912376
Effective tax rate (%): 19.08199761557822
Interest coverage ratio: 61.641129032258064
COGS to revenue (%): 71.01954074083096
SG&A to revenue (%): 16.779218248579657
Free cash flow (dilution-adjusted): -6202000
Buyback yield (%): 0.5449959611620845
Retained earnings: 50000000
Receivables turnover: 1.2445133226226923
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.304149226917417
FCF margin (%): -3.776618093910036
Revenue growth (%): 8.626859550598958
Rule of 40 score: 4.850241456688922
Financial ratios for IBT.L — annual report dated 2021-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.08246575342465753
Shares outstanding: 31802834
Market cap (USD): 2622644.666849315
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBT.L — annual report dated 2022-08-31
Total revenue: -24539534.88372093
Net income: -26131395.348837208
Capital expenditures: 0
Operating cash flow: 1306976.7441860465
Net tangible assets: 331266279.0697675
Owner earnings: -26131395.348837208
Return on net tangible assets (%): -7.888335456967449
Buffett classification: The Gruesome
Stock price: 0.06534883720930233
Shares outstanding: 31802834
Book value: 331266279.0697674
P/B ratio: 0.006273739143315468
Market cap (USD): 2078278.2218604654
Debt to equity: 0.14032131812741105
Free cash flow (dilution-adjusted): 1306976.7441860465
Buyback yield (%): 197.72628526621264
Receivables turnover: -1.5818904130125178
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBT.L — annual report dated 2023-08-31
Total revenue: 10751898.734177215
Net income: 8624050.632911392
Capital expenditures: 0
Operating cash flow: 34555696.20253164
Net tangible assets: 342173417.721519
Owner earnings: 8624050.632911392
Return on net tangible assets (%): 2.5203742272961
Buffett classification: The Gruesome
Stock price: 0.07329113924050633
P/E ratio: 0.2702750753852929
Shares outstanding: 31802834
Book value: 342173417.721519
P/B ratio: 0.006811943342816026
Market cap (USD): 2330865.934936709
Debt to equity: 0.12013302899928602
Effective tax rate (%): 1.7591925018024515
COGS to revenue (%): 0
SG&A to revenue (%): 18.35413232870261
Free cash flow (dilution-adjusted): 34555696.20253164
Buyback yield (%): 541.8749983652922
Receivables turnover: 3.123942625965429
Capitalized R&D asset: 0
FCF margin (%): 321.3915705203673
Rule of 40 score: 321.3915705203673
Financial ratios for IBT.L — annual report dated 2024-08-31
Total revenue: 5104947.75
Net income: 51152631.578947365
Capital expenditures: 0
Operating cash flow: 59673684.21052632
Net tangible assets: 371401315.78947365
Owner earnings: 51152631.578947365
Return on net tangible assets (%): 13.772873009406055
Buffett classification: The Gruesome
Stock price: 0.08394736842105263
P/E ratio: 0.052192118767362905
Shares outstanding: 31802834
Book value: 371401315.7894737
P/B ratio: 0.0071883542387472755
Market cap (USD): 2669764.222631579
Debt to equity: 0.08087081288859758
Effective tax rate (%): 0.34605624054753786
COGS to revenue (%): 0
SG&A to revenue (%): 29.099735953016832
Free cash flow (dilution-adjusted): 59673684.21052632
Buyback yield (%): 796.443285683775
Receivables turnover: 35.59413110091744
Capitalized R&D asset: 0
FCF margin (%): 1168.9381974678647
Revenue growth (%): -52.52050008829762
Rule of 40 score: 1116.417697379567
Financial ratios for IBT.L — quarterly report dated 2025-02-28
Capital expenditures: 0
Net tangible assets: 347574683.5443038
Buffett classification: The Gruesome
Stock price: 0.08329113924050632
Shares outstanding: 31802834
Book value: 347574683.5443038
P/B ratio: 0.0076210794408996885
Market cap (USD): 2648894.2749367086
Debt to equity: 0.13015325000728376
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBT.L — annual report dated 2025-08-31
Total revenue: -236486.48648648648
Net income: -1581081.0810810812
Capital expenditures: 0
Operating cash flow: 38693243.24324325
Net tangible assets: 337039189.1891892
Owner earnings: -1581081.0810810812
Return on net tangible assets (%): -0.46910897361362264
Buffett classification: The Gruesome
Stock price: 0.0895945945945946
Shares outstanding: 31802834
Book value: 337039189.1891892
P/B ratio: 0.008454097062255172
Market cap (USD): 2849362.019189189
Debt to equity: 0.11870862719468825
Free cash flow (dilution-adjusted): 38693243.24324325
Buyback yield (%): 971.7680309737682
Receivables turnover: -3.5714285714285716
Capitalized R&D asset: 0
Revenue growth (%): -104.63249572900106
Rule of 40 score: -104.63249572900106
Financial ratios for IBT.L — quarterly report dated 2025-08-31
Capital expenditures: 0
Net tangible assets: 337039189.1891892
Buffett classification: The Gruesome
Stock price: 0.0895945945945946
Shares outstanding: 31802834
Book value: 337039189.1891892
P/B ratio: 0.008454097062255172
Market cap (USD): 2849362.019189189
Debt to equity: 0.11870862719468825
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IDXX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 658.46
Shares outstanding: 78882997
Market cap (USD): 51941298204.62
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IDXX — annual report dated 2022-12-31
Total revenue: 3367324000
Gross profit: 2004338000
Operating income: 898765000
Net income: 679089000
Capital expenditures: 148838000
Operating cash flow: 542984000
Depreciation & amortization: 111900000
Net tangible assets: 149270000
Owner earnings: 642151000
Return on net tangible assets (%): 430.1942788236082
Capex to operating income (%): 16.56027993969503
Buffett classification: The Great
Stock price: 407.96
P/E ratio: 47.38864486999495
Shares outstanding: 78882997
Book value: 608737000
P/B ratio: 52.86537118019769
Market cap (USD): 32181107456.12
Debt to equity: 2.414890174246021
Current ratio: 0.8913046820569298
Quick ratio: 0.5936658189047931
Effective tax rate (%): 21.03359179136065
Interest coverage ratio: 22.549174569722513
COGS to revenue (%): 40.47682967246395
R&D to revenue (%): 7.567433368455188
SG&A to revenue (%): 25.264958168563524
Free cash flow (dilution-adjusted): 334376000
Buyback yield (%): 2.5471808299876035
Retained earnings: 3599529000
Inventory turnover: 3.705548592665494
Receivables turnover: 6.859448811679701
Capitalized R&D asset: 254820000
ROCI (R&D-adjusted, %): 60.51964512040557
FCF margin (%): 9.930021583904608
Rule of 40 score: 9.930021583904608
Financial ratios for IDXX — annual report dated 2023-12-31
Total revenue: 3660953000
Gross profit: 2189970000
Operating income: 1097128000
Net income: 845042000
Capital expenditures: 133631000
Operating cash flow: 906510000
Depreciation & amortization: 114908000
Net tangible assets: 1034069000
Owner earnings: 826319000
Return on net tangible assets (%): 79.9094644554667
Capex to operating income (%): 12.180073792665942
Buffett classification: The Great
Stock price: 555.05
P/E ratio: 51.812818161523325
Shares outstanding: 78882997
Book value: 1484530000
P/B ratio: 29.49351477225115
Market cap (USD): 43784007484.85
Debt to equity: 0.7189837861141236
Current ratio: 1.5713926900090063
Quick ratio: 1.171746639945268
Effective tax rate (%): 20.367403710600314
Interest coverage ratio: 26.385320218368967
COGS to revenue (%): 40.18033009437706
R&D to revenue (%): 5.215882312610951
SG&A to revenue (%): 24.635415969557652
Free cash flow (dilution-adjusted): 713140000
Buyback yield (%): 0.16426088914973241
Retained earnings: 4444571000
Inventory turnover: 3.8681373296658794
Receivables turnover: 6.91361552174767
Capitalized R&D asset: 361680400
ROCI (R&D-adjusted, %): 42.676544702792526
Rosenberg metric: 0.7284828506396672
FCF margin (%): 19.479627299230557
Revenue growth (%): 8.719950916514122
Rule of 40 score: 28.19957821574468
Financial ratios for IDXX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 505.22
Shares outstanding: 78882997
Market cap (USD): 39853267744.340004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IDXX — annual report dated 2024-12-31
Total revenue: 3897504000
Gross profit: 2378927000
Operating income: 1128337000
Net income: 887867000
Capital expenditures: 120922000
Operating cash flow: 929001000
Depreciation & amortization: 129936000
Net tangible assets: 1078537000
Owner earnings: 896881000
Return on net tangible assets (%): 83.15718422270167
Capex to operating income (%): 10.716833711914083
Buffett classification: The Great
Stock price: 413.44
P/E ratio: 36.73228792114134
Shares outstanding: 78882997
Book value: 1595313000
P/B ratio: 20.443252377232557
Market cap (USD): 32613386279.68
Debt to equity: 0.6186547718222066
Current ratio: 1.3108680832574846
Quick ratio: 0.9532772240513299
Effective tax rate (%): 19.999801771621083
Interest coverage ratio: 36.158852747957056
COGS to revenue (%): 38.962807991986665
R&D to revenue (%): 5.639301460627109
SG&A to revenue (%): 26.44764444116029
Free cash flow (dilution-adjusted): 737784000
Buyback yield (%): 2.5665350810919008
Retained earnings: 5332438000
Inventory turnover: 3.9766128884431375
Receivables turnover: 6.943511319826978
Capitalized R&D asset: 431819770
ROCI (R&D-adjusted, %): 42.38342844004009
Rosenberg metric: 0.9895575304659311
FCF margin (%): 18.929653439739898
Revenue growth (%): 6.46145962540355
Rule of 40 score: 25.391113065143447
Financial ratios for IDXX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 413.44
Shares outstanding: 78882997
Market cap (USD): 32613386279.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IDXX — quarterly report dated 2025-03-31
Total revenue: 998427000
Gross profit: 623379000
Operating income: 316534000
Net income: 242677000
Capital expenditures: 30026000
Operating cash flow: 237962000
Depreciation & amortization: 34063000
Net tangible assets: 933119000
Owner earnings: 246714000
Return on net tangible assets (%): 26.43971454873387
Capex to operating income (%): 9.485868816620016
Buffett classification: The Great
Stock price: 419.95
P/E ratio: 34.12654947744327
Shares outstanding: 78882997
Book value: 1448013000
P/B ratio: 22.877498054333767
Market cap (USD): 33126914590.149998
Debt to equity: 0.7315949511503005
Current ratio: 1.15965316362337
Quick ratio: 0.8111384045069014
Effective tax rate (%): 21.73830316946376
Interest coverage ratio: 41.29063396817114
COGS to revenue (%): 37.56388799581742
R&D to revenue (%): 5.91540493195797
SG&A to revenue (%): 24.817437829706126
Free cash flow (dilution-adjusted): 193321000
Buyback yield (%): 1.210164016057207
Retained earnings: 5575115000
Inventory turnover: 0.9471220014798466
Receivables turnover: 1.652606210678421
Capitalized R&D asset: 59061000
ROCI (R&D-adjusted, %): 16.658171611350518
FCF margin (%): 19.362557302637047
Rule of 40 score: 19.362557302637047
Financial ratios for IDXX — quarterly report dated 2025-06-30
Total revenue: 1109457000
Gross profit: 694732000
Operating income: 373046000
Net income: 293989000
Capital expenditures: 34102000
Operating cash flow: 185743000
Depreciation & amortization: 35772000
Net tangible assets: 940610000
Owner earnings: 295659000
Return on net tangible assets (%): 31.43268729866789
Capex to operating income (%): 9.141499975874288
Buffett classification: The Great
Stock price: 536.34
P/E ratio: 78.83507919447105
Shares outstanding: 78882997
Book value: 1458827000
P/B ratio: 29.001455697611853
Market cap (USD): 42308106610.98
Debt to equity: 0.8481272967939311
Current ratio: 1.1131458966565349
Quick ratio: 0.7923758865248227
Effective tax rate (%): 18.86646134145803
Interest coverage ratio: 32.95168271354121
COGS to revenue (%): 37.38089894425832
R&D to revenue (%): 5.579125644346739
SG&A to revenue (%): 23.41577907030196
Free cash flow (dilution-adjusted): 136787000
Buyback yield (%): 0.7991494469578873
Retained earnings: 5869104000
Inventory turnover: 1.0563981211664255
Receivables turnover: 1.672213798446341
Capitalized R&D asset: 101468870
ROCI (R&D-adjusted, %): 17.8693802915313
Rosenberg metric: 1.2081238042024347
FCF margin (%): 12.329184456900988
Revenue growth (%): 11.120492534757172
Rule of 40 score: 23.44967699165816
Financial ratios for IDXX — quarterly report dated 2025-09-30
Total revenue: 1105239000
Gross profit: 683354000
Operating income: 354846000
Net income: 274610000
Capital expenditures: 31114000
Operating cash flow: 402340000
Depreciation & amortization: 36627000
Net tangible assets: 1032745000
Owner earnings: 280123000
Return on net tangible assets (%): 27.124120668703313
Capex to operating income (%): 8.768310760160745
Buffett classification: The Great
Stock price: 638.89
P/E ratio: 62.121347054923355
Shares outstanding: 78882997
Book value: 1561186000
P/B ratio: 32.28158461152611
Market cap (USD): 50397557953.33
Debt to equity: 0.7128958368829851
Current ratio: 1.179934510880636
Quick ratio: 0.8671364926494495
Effective tax rate (%): 20.350029439831076
Interest coverage ratio: 33.30323791647114
COGS to revenue (%): 38.17138193639566
R&D to revenue (%): 5.737673028186664
SG&A to revenue (%): 23.985129008295942
Free cash flow (dilution-adjusted): 343443000
Buyback yield (%): 0.4766004738214289
Retained earnings: 6143714000
Inventory turnover: 1.0774356171660315
Receivables turnover: 1.5458623207257407
Capitalized R&D asset: 124376790
ROCI (R&D-adjusted, %): 15.792790137595253
Rosenberg metric: -0.18381854017900418
FCF margin (%): 31.07409347661456
Revenue growth (%): -0.3801859828727026
Rule of 40 score: 30.693907493741857
Financial ratios for IDXX — quarterly report dated 2025-12-31
Total revenue: 1090579000
Gross profit: 658114000
Operating income: 315605000
Net income: 248188000
Capital expenditures: 29434000
Operating cash flow: 355760000
Depreciation & amortization: 38721000
Net tangible assets: 1081536000
Owner earnings: 257475000
Return on net tangible assets (%): 23.806419758565596
Capex to operating income (%): 9.326214730438364
Buffett classification: The Great
Stock price: 676.53
P/E ratio: 50.37142740141241
Shares outstanding: 78882997
Book value: 1605383000
P/B ratio: 33.242356472200086
Market cap (USD): 53366713960.409996
Debt to equity: 0.6079932327675078
Current ratio: 1.2306839923608173
Quick ratio: 0.9018613979286464
Effective tax rate (%): 19.152262999133498
Interest coverage ratio: 34.26764386536374
COGS to revenue (%): 39.654623828260036
R&D to revenue (%): 6.128212628337791
SG&A to revenue (%): 25.27794868597323
Free cash flow (dilution-adjusted): 310015000
Buyback yield (%): 0.44554738779006
Retained earnings: 6391902000
Inventory turnover: 1.1448262899861286
Receivables turnover: 1.5732734556565218
Capitalized R&D asset: 129747390
ROCI (R&D-adjusted, %): 13.654860079263429
Rosenberg metric: -0.39801308838602856
FCF margin (%): 28.426643095089855
Revenue growth (%): -1.3264099439125836
Rule of 40 score: 27.10023315117727
Financial ratios for IDXX — annual report dated 2025-12-31
Total revenue: 4303702000
Gross profit: 2659579000
Operating income: 1360031000
Net income: 1059464000
Capital expenditures: 124676000
Operating cash flow: 1181805000
Depreciation & amortization: 145183000
Net tangible assets: 1081536000
Owner earnings: 1079971000
Return on net tangible assets (%): 99.85529839043731
Capex to operating income (%): 9.167143984218008
Buffett classification: The Great
Stock price: 676.53
P/E ratio: 50.37142740141241
Shares outstanding: 78882997
Book value: 1605383000
P/B ratio: 33.242356472200086
Market cap (USD): 53366713960.409996
Debt to equity: 0.6079932327675078
Current ratio: 1.2306839923608173
Quick ratio: 0.9018613979286464
Effective tax rate (%): 19.991481578535993
Interest coverage ratio: 35.005430865849895
COGS to revenue (%): 38.20252889256738
R&D to revenue (%): 5.83699800776169
SG&A to revenue (%): 24.359051811672835
Free cash flow (dilution-adjusted): 983566000
Buyback yield (%): 2.280380240205164
Retained earnings: 6391902000
Inventory turnover: 4.352341193786465
Receivables turnover: 6.208537041017555
Capitalized R&D asset: 461481470
ROCI (R&D-adjusted, %): 52.21048959538199
Rosenberg metric: 1.2768981582587173
FCF margin (%): 22.853952248552524
Revenue growth (%): 10.422003415519265
Rule of 40 score: 33.27595566407179
Financial ratios for IMFA.NS — annual report dated 2022-03-31
Capital expenditures: 11486219.174469208
Buffett classification: The Gruesome
Stock price: 4.746538309376237
Shares outstanding: 53954106
Market cap (USD): 256095231.07714626
Buyback yield (%): 0
Retained earnings: 159727020.96795464
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMFA.NS — annual report dated 2023-03-31
Total revenue: 321484774.66504264
Gross profit: 135399512.78928137
Operating income: 48635809.98781974
Net income: 27500609.013398297
Capital expenditures: 28788063.337393425
Operating cash flow: 18384896.467722293
Depreciation & amortization: 13066991.473812426
Net tangible assets: 224956151.0353228
Owner earnings: 11779537.149817295
Return on net tangible assets (%): 5.236370330663981
Capex to operating income (%): 59.19108439769597
Buffett classification: The Good
Stock price: 3.158708891595615
P/E ratio: 6.197146916901408
Shares outstanding: 53954106
Book value: 231817295.98051155
P/B ratio: 0.7351708320099621
Market cap (USD): 170425314.36029232
Debt to equity: 0.17892308823993025
Current ratio: 2.257854544361264
Quick ratio: 1.2845374462583807
Effective tax rate (%): 30.286843486584125
Interest coverage ratio: 15.240458015267178
COGS to revenue (%): 57.88307146727084
SG&A to revenue (%): 1.7022872709224484
Free cash flow (dilution-adjusted): 18384896.467722293
Buyback yield (%): 0
Retained earnings: 166665042.6309379
Inventory turnover: 2.359584227840672
Receivables turnover: 30.815995329830702
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.082381519984313
FCF margin (%): 5.7187456192529345
Rule of 40 score: 5.7187456192529345
Financial ratios for IMFA.NS — annual report dated 2024-03-31
Total revenue: 328978294.7595635
Gross profit: 138459047.84746373
Operating income: 63565175.68053723
Net income: 41292720.94975416
Capital expenditures: 13545988.727665188
Operating cash flow: 55110924.57129152
Depreciation & amortization: 9357237.078786425
Net tangible assets: 250913778.63053125
Owner earnings: 37103969.3008754
Return on net tangible assets (%): 14.787537577005978
Capex to operating income (%): 21.310392966966628
Buffett classification: The Great
Stock price: 7.210172744721689
P/E ratio: 9.42099274640658
Shares outstanding: 53954106
Book value: 253428468.64132392
P/B ratio: 1.5350225909213095
Market cap (USD): 389018424.54702497
Debt to equity: 0.11204538786943888
Current ratio: 2.409901985423473
Quick ratio: 1.4160313870039931
Effective tax rate (%): 33.2829574517554
Interest coverage ratio: 18.354224376731302
COGS to revenue (%): 57.912406364481384
SG&A to revenue (%): 1.8298795268558514
Free cash flow (dilution-adjusted): 41494183.95491066
Buyback yield (%): 0
Retained earnings: 191802374.3854179
Inventory turnover: 2.2319093041877975
Receivables turnover: 19.98943456718158
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.13303284846001
FCF margin (%): 12.613046093280111
Revenue growth (%): 2.3309097926420996
Rule of 40 score: 14.943955885922211
Financial ratios for IMFA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 276950549.4505495
Buffett classification: The Gruesome
Stock price: 8.069995222169135
Shares outstanding: 53954106
Book value: 279102962.2551362
P/B ratio: 1.5600313737923948
Market cap (USD): 435409377.6364071
Debt to equity: 0.12686110457278582
Current ratio: 2.912149267384824
Quick ratio: 1.918915508729871
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMFA.NS — quarterly report dated 2024-12-31
Total revenue: 74976104.44107704
Gross profit: 34049423.00967479
Operating income: 13345378.249213194
Net income: 10883552.861638885
Capital expenditures: 0
Depreciation & amortization: 1595757.0812449001
Owner earnings: 12479309.942883786
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.800792633174028
P/E ratio: 12.146608082323016
Shares outstanding: 53954106
Market cap (USD): 528793004.61429065
Effective tax rate (%): 24.378391512108205
Interest coverage ratio: 16.96148148148148
COGS to revenue (%): 54.58630017723329
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMFA.NS — quarterly report dated 2025-03-31
Total revenue: 66302314.70657002
Gross profit: 28896422.726209957
Operating income: 6623801.730184709
Net income: 5541267.243394903
Capital expenditures: 0
Depreciation & amortization: 1621463.6427402385
Net tangible assets: 273270984.33481413
Owner earnings: 7162730.886135141
Return on net tangible assets (%): 2.6211091907801296
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.05858326525849
P/E ratio: 17.181969979770287
Shares outstanding: 53954106
Book value: 275558802.8992284
P/B ratio: 1.3820627238058347
Market cap (USD): 380839549.7035827
Debt to equity: 0.16486999019994658
Current ratio: 2.6922787927699776
Quick ratio: 1.6679560855469129
Effective tax rate (%): 25.553635935291346
Interest coverage ratio: 6.053418803418803
COGS to revenue (%): 56.417173587234416
Buyback yield (%): 0
Retained earnings: 218668459.20037407
Inventory turnover: 0.4346532636011682
Receivables turnover: 5.010159010600707
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.304404234637644
Revenue growth (%): -11.568738865759103
Rule of 40 score: -11.568738865759103
Financial ratios for IMFA.NS — annual report dated 2025-03-31
Total revenue: 296309328.9689034
Gross profit: 130427870.00233808
Operating income: 55847556.69862053
Net income: 44344166.47182605
Capital expenditures: 13325929.389759175
Operating cash flow: 68429974.2810381
Depreciation & amortization: 6382978.723404255
Net tangible assets: 273270984.33481413
Owner earnings: 37401215.80547113
Return on net tangible assets (%): 13.686493608720204
Capex to operating income (%): 23.861257640458845
Buffett classification: The Great
Stock price: 7.05858326525849
P/E ratio: 8.588267183814317
Shares outstanding: 53954106
Book value: 275558802.8992284
P/B ratio: 1.3820627238058347
Market cap (USD): 380839549.7035827
Debt to equity: 0.16486999019994658
Current ratio: 2.6922787927699776
Quick ratio: 1.6679560855469129
Effective tax rate (%): 26.218124525879677
Interest coverage ratio: 20.74337820234477
COGS to revenue (%): 55.982529994515964
SG&A to revenue (%): 2.2827789460394614
Free cash flow (dilution-adjusted): 54892447.97755436
Buyback yield (%): 0
Retained earnings: 218668459.20037407
Inventory turnover: 1.9275283569924608
Receivables turnover: 22.390724381625443
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.429226808526217
FCF margin (%): 18.525386348303304
Revenue growth (%): -9.930431980181691
Rule of 40 score: 8.594954368121613
Financial ratios for IMFA.NS — quarterly report dated 2025-06-30
Total revenue: 75069038.14650129
Gross profit: 33162883.22021999
Operating income: 12956938.91879242
Net income: 10828457.758015446
Capital expenditures: 0
Depreciation & amortization: 1723613.3863795928
Owner earnings: 12552071.144395038
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.111748186285983
P/E ratio: 18.03879261638208
Shares outstanding: 53954106
Market cap (USD): 491616227.48818165
Effective tax rate (%): 26.386126799777266
Interest coverage ratio: 15.796005706134094
COGS to revenue (%): 55.82348723384356
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 13.222348991478809
Rule of 40 score: 13.222348991478809
Financial ratios for IMFA.NS — quarterly report dated 2025-12-31
Total revenue: 78292302.55096358
Gross profit: 39396234.82232372
Operating income: 16593516.765066281
Net income: 14644090.453380862
Capital expenditures: 0
Depreciation & amortization: 1709925.3648212098
Owner earnings: 16354015.818202073
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.622479670268465
P/E ratio: 21.405903667720548
Shares outstanding: 53954106
Market cap (USD): 896851030.1125098
Effective tax rate (%): 18.565322430774952
Interest coverage ratio: 16.069039913700106
COGS to revenue (%): 49.68057709545693
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 4.293733453959964
Rule of 40 score: 4.293733453959964
Financial ratios for INEO.V — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.4193548387096775
Shares outstanding: 52048016
Market cap (USD): 125922619.35483871
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INEO.V — annual report dated 2022-06-30
Total revenue: 965189.9224806201
Gross profit: 390644.96124031005
Operating income: -2529327.906976744
Net income: -2552479.8449612404
Capital expenditures: 268255.0387596899
Operating cash flow: -2386214.7286821706
Depreciation & amortization: 123605.42635658915
Net tangible assets: 1816231.007751938
Owner earnings: -2697129.4573643412
Return on net tangible assets (%): -148.50145415713092
Buffett classification: The Gruesome
Stock price: 1.4728682170542635
Shares outstanding: 52048016
Book value: 1820434.8837209302
P/B ratio: 42.11074464275296
Market cap (USD): 76659868.52713178
Debt to equity: 0.11228426975239326
Current ratio: 2.9426144890169104
Quick ratio: 2.7474606955453273
Interest coverage ratio: -78.3242834509578
COGS to revenue (%): 59.526622466558784
R&D to revenue (%): 57.707484167874746
SG&A to revenue (%): 232.01450491729548
Free cash flow (dilution-adjusted): -2826503.100775194
Buyback yield (%): 0
Retained earnings: -9235531.782945735
Inventory turnover: 4.781295762290905
Receivables turnover: 5.612657040980539
Capitalized R&D asset: 556986.8217054263
ROCI (R&D-adjusted, %): -88.92609638783084
FCF margin (%): -292.8442408009028
Rule of 40 score: -292.8442408009028
Financial ratios for INEO.V — annual report dated 2023-06-30
Total revenue: 1134592.4812030075
Gross profit: 280681.2030075188
Operating income: -2411539.84962406
Net income: -2504880.4511278193
Capital expenditures: 690208.2706766917
Operating cash flow: -1978531.5789473683
Depreciation & amortization: 167307.51879699246
Net tangible assets: 500436.0902255639
Owner earnings: -3027781.2030075183
Return on net tangible assets (%): -605.0285465308452
Buffett classification: The Gruesome
Stock price: 0.4135338345864662
Shares outstanding: 52048016
Book value: 502882.70676691714
P/B ratio: 42.80046887568517
Market cap (USD): 21523615.639097746
Debt to equity: 1.646118468857744
Current ratio: 0.9881423963591132
Quick ratio: 0.7312305706794154
Interest coverage ratio: -25.83737191467423
COGS to revenue (%): 75.26149629425424
R&D to revenue (%): 53.224436185891655
SG&A to revenue (%): 169.3148081388568
Free cash flow (dilution-adjusted): -2786457.1428571427
Buyback yield (%): 0
Retained earnings: -11462651.879699247
Inventory turnover: 4.302520817390382
Receivables turnover: 5.160642529077622
Capitalized R&D asset: 977061.6216704552
ROCI (R&D-adjusted, %): -102.35417847776374
Rosenberg metric: -0.19742613998675146
FCF margin (%): -245.59101078324304
Revenue growth (%): 17.551215027919937
Rule of 40 score: -228.0397957553231
Financial ratios for INEO.V — annual report dated 2024-06-30
Total revenue: 990979.5620437956
Gross profit: 322226.27737226273
Operating income: -2004440.8759124086
Net income: -2254545.2554744524
Capital expenditures: 294770.802919708
Operating cash flow: -627210.2189781021
Depreciation & amortization: 306024.81751824816
Net tangible assets: -1540108.02919708
Owner earnings: -2243291.2408759124
Buffett classification: The Gruesome
Stock price: 0.36496350364963503
Shares outstanding: 52048016
Book value: -1539316.0583941606
Market cap (USD): 18995626.277372263
Debt to equity: -0.9435065246059132
Current ratio: 0.14710428481954574
Quick ratio: 0.051488908602214695
Interest coverage ratio: -9.451135065185369
COGS to revenue (%): 67.48406428204194
R&D to revenue (%): 55.81876518257389
SG&A to revenue (%): 148.0849885315864
Free cash flow (dilution-adjusted): -1069594.8905109488
Buyback yield (%): 0
Retained earnings: -13382521.16788321
Inventory turnover: 4.235296293043273
Receivables turnover: 12.460461103564741
Capitalized R&D asset: 1141558.1081629551
ROCI (R&D-adjusted, %): -228.59164341051485
Rosenberg metric: 0.06879685256767878
FCF margin (%): -107.93309281828347
Revenue growth (%): -12.657665332572913
Rule of 40 score: -120.59075815085639
Financial ratios for INEO.V — quarterly report dated 2024-09-30
Capital expenditures: 118437.03703703704
Buffett classification: The Gruesome
Stock price: 0.40740740740740744
Shares outstanding: 52048016
Market cap (USD): 21204747.25925926
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INEO.V — quarterly report dated 2024-12-31
Total revenue: 205072.7272727273
Gross profit: 106881.11888111889
Operating income: -534122.3776223776
Net income: -624883.9160839161
Capital expenditures: 244631.46853146853
Operating cash flow: -330456.6433566434
Depreciation & amortization: 88778.32167832168
Net tangible assets: -361914.68531468534
Owner earnings: -780737.0629370629
Buffett classification: The Gruesome
Stock price: 0.27972027972027974
Shares outstanding: 52048016
Book value: -361914.6853146851
Market cap (USD): 14558885.594405595
Debt to equity: -3.606067573782024
Current ratio: 0.5553203556337162
Quick ratio: 0.5004365094565615
Interest coverage ratio: -7.551037557710749
COGS to revenue (%): 47.88135882204506
R&D to revenue (%): 76.20424614839013
SG&A to revenue (%): 193.07835528245138
Free cash flow (dilution-adjusted): -613750.3496503497
Buyback yield (%): 0
Retained earnings: -13906251.74825175
Inventory turnover: 0.7313419620302611
Receivables turnover: 1.3042321924144311
Capitalized R&D asset: 156274.1258741259
ROCI (R&D-adjusted, %): -126.9274388120671
FCF margin (%): -299.28423823715957
Rule of 40 score: -299.28423823715957
Financial ratios for INEO.V — quarterly report dated 2025-03-31
Total revenue: 318881.8181818182
Gross profit: 142611.8881118881
Operating income: -525611.1888111888
Net income: -654903.4965034965
Capital expenditures: 194734.96503496505
Operating cash flow: -923279.7202797203
Depreciation & amortization: 88358.74125874127
Net tangible assets: -33640.559440559446
Owner earnings: -761279.7202797204
Buffett classification: The Gruesome
Stock price: 0.3146853146853147
Shares outstanding: 52048016
Book value: -33640.55944055924
Market cap (USD): 16378746.293706294
Debt to equity: -32.62370598262191
Current ratio: 0.46269870697175275
Quick ratio: 0.39801815907102034
Interest coverage ratio: -6.850320357998924
COGS to revenue (%): 55.27751035633693
R&D to revenue (%): 42.58521362891749
SG&A to revenue (%): 139.2578086451565
Free cash flow (dilution-adjusted): -1152944.055944056
Buyback yield (%): 0
Retained earnings: -14561155.244755246
Inventory turnover: 1.3517125252709419
Receivables turnover: 1.0348136885580719
Capitalized R&D asset: 240500.16783216788
ROCI (R&D-adjusted, %): -91.25163264488486
Rosenberg metric: 0.22864161953175333
FCF margin (%): -361.55841763504907
Revenue growth (%): 55.496941218193086
Rule of 40 score: -306.06147641685595
Financial ratios for INEO.V — annual report dated 2025-06-30
Total revenue: 1029394.1605839415
Gross profit: 444656.9343065693
Operating income: -2310514.598540146
Net income: -2617945.9854014595
Capital expenditures: 563059.8540145985
Operating cash flow: -2091353.2846715327
Depreciation & amortization: 384156.204379562
Net tangible assets: -792599.9999999999
Owner earnings: -2796849.6350364964
Buffett classification: The Gruesome
Stock price: 0.437956204379562
Shares outstanding: 52048016
Book value: -792600
Market cap (USD): 22794751.532846715
Debt to equity: -1.405291832663819
Current ratio: 0.24350830146099853
Quick ratio: 0.161992057560704
Interest coverage ratio: -8.839641768037264
COGS to revenue (%): 56.80401625220702
R&D to revenue (%): 56.168180561169144
SG&A to revenue (%): 174.16296170236907
Free cash flow (dilution-adjusted): -2782286.131386861
Buyback yield (%): 0
Retained earnings: -16000467.15328467
Inventory turnover: 3.000202238101658
Receivables turnover: 3.421457407371465
Capitalized R&D asset: 1148084.7313539323
ROCI (R&D-adjusted, %): -336.20016848580605
Rosenberg metric: 0.22133253454980675
FCF margin (%): -270.2838463556624
Revenue growth (%): 3.876426922561315
Rule of 40 score: -266.40741943310104
Financial ratios for INEO.V — quarterly report dated 2025-06-30
Total revenue: 279059.12408759125
Gross profit: 102201.4598540146
Operating income: -780651.0948905109
Net income: -786727.7372262774
Capital expenditures: 12256.934306569343
Operating cash flow: -409389.7810218978
Depreciation & amortization: 115140.14598540145
Net tangible assets: -792599.9999999999
Owner earnings: -683844.5255474453
Buffett classification: The Gruesome
Stock price: 0.437956204379562
Shares outstanding: 52048016
Book value: -792600
Market cap (USD): 22794751.532846715
Debt to equity: -1.405291832663819
Current ratio: 0.24350830146099853
Quick ratio: 0.161992057560704
Interest coverage ratio: -19.35241748697163
COGS to revenue (%): 63.376413443505406
R&D to revenue (%): 59.276086746130765
SG&A to revenue (%): 236.5608104396682
Free cash flow (dilution-adjusted): -440060.5839416058
Buyback yield (%): 0
Retained earnings: -16000467.15328467
Inventory turnover: 0.9074311266909352
Receivables turnover: 0.9275250858839743
Capitalized R&D asset: 307969.4473482722
Rosenberg metric: -0.2975807713555305
FCF margin (%): -157.6943901692601
Revenue growth (%): -12.488229752729602
Rule of 40 score: -170.1826199219897